About Us – ZIM HEALTH TECHNOLOGIES LIMITED

About Us

At ZIM Health Technologies Limited (ZHTL), we’re dedicated to pushing the boundaries of the pharmaceutical industry with our innovative research and development. We prioritize operational efficiency and innovation to deliver value to stakeholders. ZHTL plays a vital role in ZIM Group’s achievements, aiding in business growth and product development. Through involvement in ideation, development, manufacturing, and registration, we work diligently to introduce valuable pharmaceutical solutions to the market.

Dr. Chandrashekhar Mainde, an experienced leader in pharmaceutical R&D, oversees teams in R&D, QA, QC, RA, and production at ZHTL. Under his guidance, ZHTL drives product development and registration for the ZIM group, strengthening its position in the pharmaceutical industry.

Furthermore, Mr. Gautam Saigal, a seasoned professional in private equity investments, recently joined the ZHTL Board as a Non-Executive and Non-Independent Director. His expertise will support strategic initiatives and new ventures, driving our company’s growth.

We invite you to join us on our journey towards a healthier future.

xr:d:DAGCAVQpqsI:2,j:6506999977659877471,t:24041009

VISION

Making Quality Healthcare Affordable Through Drug Delivery Solutions Focusing On Patient Convenience and Treatment Adherence.

Our Product Offerings

Pellets

Tablets

DC Granules

Capsules

Dry Syrups

Taste Masked Powders

Therapy Segments

Urology

Cardiovascular and Anti - Coagulant

Anti - biotics & Anti - infectives

Gastrointestinal

Analgesics and Pain Management

Vitamins and Dietary Supplements

Central Nervous System

Skin Disorders

Rheumatology

Respiratory System

Pharmaceutical

We are dedicated to providing our customers with an extensive, scientifically-driven range of pharmaceutical products at affordable prices. Our offerings target a diverse array of therapeutic segments including Cardiovascular Diseases, Anti-infectives, Gastrointestinal Disorders, Respiratory Illnesses, Urology, Nervous System disorders, Musculoskeletal problems, NSAID / Pain Management, and Hematology. Each product is meticulously formulated and rigorously tested to ensure the highest standards of quality and efficacy. By prioritizing the well-being of the patients we serve, we strive to make a meaningful impact on healthcare.

New Innovative Products (NIP)

We have cultivated an exclusive pipeline of New Innovative Products (NIP), comprising complex generic products utilizing non-infringing development and differentiated drug delivery methods. Presently, we have developed 10 NIP, each progressing through various stages of dossier completion and registration.